CAPITAL WORLD INVESTORS – Vertex Pharmaceuticals Incorporated Transaction History
CAPITAL WORLD INVESTORS portfolio value:
$3.62B
portfolio value
CAPITAL WORLD INVESTORS quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.36% | -45.25K shares | 84.38M | $289.54 | 12.52M |
| Q2 2022 | share | Decrease | -0.76% | -96.19K shares | 236.64M | $281.79 | 12.56M |
| Q1 2022 | share | Increase | +9.94% | 1.14M shares | 775.41M | $260.97 | 12.66M |
| Q4 2021 | share | Increase | +4.33% | 478.55K shares | 527.03M | $222.45 | 11.52M |
| Q3 2021 | share | Increase | +0.24% | 26.92K shares | -218.03M | $181.39 | 11.04M |
| Q2 2021 | share | Increase | +14.06% | 1.35M shares | 145.71M | $201.63 | 11.01M |
| Q1 2021 | share | Increase | +0.03% | 3.32K shares | -206.36M | $214.89 | 9.65M |
| Q4 2020 | share | Decrease | -15.02% | -1.70M shares | -809.76M | $236.34 | 9.65M |
| Q3 2020 | share | Decrease | -9.03% | -1.12M shares | -534.03M | $272.12 | 11.36M |
| Q2 2020 | share | Decrease | -0.73% | -91.47K shares | 632.11M | $290.31 | 12.48M |
| Q1 2020 | share | Increase | +18.70% | 1.98M shares | 672.88M | $237.95 | 12.57M |
| Q4 2019 | share | Increase | +0.11% | 11.27K shares | 526.83M | $218.95 | 10.59M |
| Q3 2019 | share | Decrease | -7.53% | -862.72K shares | -305.99M | $169.42 | 10.58M |
| Q2 2019 | share | Increase | +4.91% | 535.82K shares | 92.03M | $183.38 | 11.44M |
| Q1 2019 | share | Increase | +10.46% | 1.03M shares | 370.30M | $183.95 | 10.91M |
| Q4 2018 | share | Increase | +28.33% | 2.18M shares | 153.39M | $165.71 | 9.88M |
| Q3 2018 | share | Decrease | -29.96% | -3.29M shares | -384.32M | $192.74 | 7.69M |
| Q2 2018 | share | Increase | +22.15% | 1.99M shares | 401.56M | $169.96 | 10.99M |
| Q1 2018 | share | Increase | +52.80% | 3.10M shares | 584.04M | $162.98 | 8.99M |
| Q4 2017 | share | Decrease | -49.06% | -5.67M shares | -875.26M | $149.86 | 5.88M |
| Q3 2017 | share | Decrease | -25.00% | -3.85M shares | -228.85M | $152.04 | 11.56M |
| Q2 2017 | share | Decrease | -13.88% | -2.48M shares | 29.24M | $128.87 | 15.41M |
| Q1 2017 | share | Decrease | -13.76% | -2.85M shares | 428.21M | $109.35 | 17.90M |
| Q4 2016 | share | Decrease | -6.88% | -1.53M shares | -414.86M | $73.67 | 20.75M |
| Q3 2016 | share | Increase | +2.76% | 599.58K shares | 78.10M | $87.21 | 22.29M |
| Q2 2016 | share | Increase | +0.44% | 94.63K shares | 149.17M | $86.02 | 21.69M |
| Q1 2016 | share | Increase | +4.15% | 860.25K shares | -892.61M | $79.49 | 21.59M |